S Kulkarni

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

Bhawna Sirohi, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 115 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

Seema Singhal, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 110 citations

Hematological Malignancy, Transplantation, Cd34+ Cells/kg +6

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

Seema Singhal, R Powles, Bhawna Sirohi et al. · Bone Marrow Transplantation · 2002 · 83 citations

Hematological Malignancy, Survival Benefit, Medicine +6

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

R Powles, Noopur Raje, S Milan et al. · Bone Marrow Transplantation · 1997 · 65 citations

Unselected Myeloma Patients, Prognostic Evaluation, Hematological Malignancy +6

Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients

Jayesh Mehta, R Powles, S Kulkarni et al. · Bone Marrow Transplantation · 1997 · 62 citations

Transplantation, Immunology, Hematology +11